01 abril 2016

INTERNATIONAL JOURNAL OF CARDIOLOGY. Data supporting the use of the radial approach as the default strategy in octogenarians undergoing primary-PCI?

Ashan Gunarathne, Albert Alahmar, Anthony H. Gershlick

Background: There is a significant increase in the number of octogenarians undergoing Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction Objective: To analyze one year all cause mortality in octogenarians who are admitted with a STEMI and received PPCI in a tertiary cardiac centre in the UK, and to observe the impact of the mode of vascular access on mortality.

01 abril 2016

INTERNATIONAL JOURNAL OF CARDIOLOGY. Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction

Zhishan Sun, Jianping Zeng, He Huang

Objective: To determine whether tirofiban can prevent microcirculation dysfunction during delayed percutaneous coronary intervention (PCI) of spontaneously recanalized and severe narrowing coronary artery in patients with acute myocardial infarction.

01 marzo 2016

INTERNATIONAL JOURNAL OF CARDIOLOGY. Comparison of second- and first-generation drug eluting stent for percutaneous coronary chronic total occlusion intervention

Min Soo Cho1, Pil Hyung Lee1, Seung-Whan Lee, Mineok Chang, Jae-Hyung Roh, Sung-Han Yoon, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park

Background: The performance of contemporary second-generation drug-eluting stents (DESs) for percutaneous chronic total occlusion (CTO) intervention is not well established. The present study compared the efficacy and safety outcomes of second-generation DESs with those of first-generation DESs in CTO-percutaneous coronary intervention (PCI).

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention. The ExcelsiorLOAD Trial

Willibald Hochholzer, MDa; Michael Amann, MDa; Alexander Titova; Iris Younasa; Nikolaus Löffelhardt, MDa; Florian Riede, MDa; Clemens Potocnik, MDa; Christian Stratz, MDa; Dieter Hauschke, PhDb; Dietmar Trenk, PhDa; Franz-Josef Neumann, MDa; Christian M. Valina, MDa

Objectives: This randomized trial investigated to what extent loading with prasugrel can provide a more rapid peri-interventional antiplatelet effect than clopidogrel 600 mg.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction. The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial

Fikret Er, MDa; Kristina M. Dahlem, MDb; Amir M. Nia, MDc; Erland Erdmann, MD, PhDb; Johannes Waltenberger, MDd; Martin Hellmich, PhDe; Kathrin Kuhre; Minh Tam Leb; Tina Herrfurthb; Zulfugar Taghiyev, MDf; Esther Biesenbach, MDg; Dilek Yüksel, MDa; Aslihan Eran-Ergöknil, MDa; Maria Vanezi, MDb; Evren Caglayan, MDb; Natig Gassanov, MDa

Objectives: This study sought to evaluate the role of esmolol-induced tight sympathetic control in patients with ST-segment elevation myocardial infarction (STEMI).

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve

Oliver Husser, MDa; Costanza Pellegrini, MDa; Thorsten Kessler, MDa; Christof Burgdorf, MDa; Hannah Thallera; N. Patrick Mayr, MDb; Albert M. Kasel, MDa; Adnan Kastrati, MDa,c; Heribert Schunkert, MDa,c; Christian Hengstenberg, MDa,c

Objectives: This study investigates the influence of implantation depth and prosthesis oversizing on conduction abnormalities (CA) and permanent pacemaker implantation (PPI) after SAPIEN 3 (Edwards Lifesciences, Irvine, California) implantation.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial. 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease

Konstantinos Katsanos, MSc, MD, PhDa,b; Stavros Spiliopoulos, MD, PhDb; Athanasios Diamantopoulos, MD, PhDa; Dimitris Siablis, MD, PhDb; Dimitris Karnabatidis, MD, PhDb; Dierk Scheinert, MDc

Objectives: The authors sought to report the wound healing outcomes, health-related quality-of-life changes and quality-adjusted life-years (QALYs) gain in the 2 treatment arms of the ACHILLES (Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease) multicenter randomized trial.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement. Experience From the PARTNER Continued Access Registry

Nirat Beohar, MDa; Ajay J. Kirtane, MD, SMb; Eugene Blackstone, MDc; Ron Waksman, MDd; David Holmes, Jr, MDe; Sa’ar Minha, MDd; Oluseun Alli, MDf; Rakesh M. Suri, MD, DPhilc; Lars G. Svensson, MD, PhDc; Martin Leon, MDb; Susheel Kodali, MDb

Objectives: The aim of this study was to examine trends in the rates of complications and outcomes of patients undergoing transfemoral transcatheter aortic valve replacement (TF-TAVR).

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve. United Kingdom Experience

Rajiv Rampat, MBBSa; M. Zeeshan Khawaja, MBBSa; Jonathan Byrne, MDb; Philip MacCarthy, MDb; Daniel J. Blackman, MDc; Arvindra Krishnamurthy, MDc; Ashan Gunarathne, MDd; Jan Kovac, MDd; Adrian Banning, MDe; Raj Kharbanda, MDe; Sami Firoozi, MDf; Stephen Brecker, MDf; Simon Redwood, MDg; Vinayak Bapat, MDg; Michael Mullen, MDh; Suneil Aggarwal, MDh; Ganesh Manoharan, MDi; Mark S. Spence, MDi; Saib Khogali, MDj; Maureen Dooley, MBBSa; James Cockburn, MDa; Adam de Belder, MDa; Uday Trivedi, MDa; David Hildick-Smith, MDa

Objectives: This study sought to present the U.K. experience to date with the second-generation LOTUS bioprosthesis (Boston Scientific, Natick, Massachusetts).

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis. Results of the REPRISE II Study

Ian T. Meredith, AM, MBBS, PhDa; Darren L. Walters, MDb; Nicolas Dumonteil, MDc; Stephen G. Worthley, MDd; Didier Tchétché, MDe; Ganesh Manoharan, MDf; Daniel J. Blackman, MDg; Gilles Rioufol, MDh; David Hildick-Smith, MDi; Robert J. Whitbourn, MDj; Thierry Lefèvre, MDk; Rüdiger Lange, MDl; Ralf Müller, MDm; Simon Redwood, MDn; Ted E. Feldman, MDo; Dominic J. Allocco, MDp; Keith D. Dawkins, MDp

Objectives: This analysis presents the first report of 1-year outcomes of the 120 patients enrolled in the REPRISE II (Repositionable Percutaneous Placement of Stenotic Aortic Valve Through Implantation of Lotus Valve System–Evaluation of Safety and Performance) study.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Endovascular Repair for Pulmonary Artery and Aortic Dissection Associated With Patent Ductus Arteriosus

Yinsu Zhu, MD; Lijun Tang, MD, PhD; Haibin Shi, MD, PhD

A 26-year-old female patient was admitted to our center with chest pain and dyspnea. She had a 2-year history of hypertension (highest systolic pressure was 180 mm Hg) and retrosternal chest pain for more than 1 year without any previous interventional procedure. Thoracic computed tomography angiography (CTA) revealed a Stanford type B aortic dissection and main pulmonary artery dissection accompanied with patent ductus arteriosus (PDA)

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. 1-Year Follow-Up Optical Frequency Domain Imaging of Multiple Bioresorbable Vascular Scaffolds for the Treatment of Spontaneous Coronary Artery Dissection

Jonathan Watt, MB, ChB, MD; Mohaned Egred, MB, ChB, MD; Ayush Khurana, MB, ChB; Alan J. Bagnall, MB, ChB, PhD; Azfar G. Zaman, MB, ChB, MD

A 32-year-old woman with chest pain and anterior ST-segment elevation myocardial infarction was referred to our institution for primary percutaneous coronary intervention. Coronary angiography showed severe left main stem (LMS) and left anterior descending coronary artery (LAD) stenosis

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction. A Report From the CathPCI Registry

Siddharth A. Wayangankar, MD, MPHa; Sripal Bangalore, MD, MHAb; Lisa A. McCoy, MSc; Hani Jneid, MDd; Faisal Latif, MDe; Wassef Karrowni, MDf; Konstantinos Charitakis, MDg; Dmitriy N. Feldman, MDg; Habib A. Dakik, MDh; Laura Mauri, MDi; Eric D. Peterson, MD, MPHc; John Messenger, MDj; Mathew Roe, MDc; Debabrata Mukherjee, MDk; Andrew Klein, MDl

Objectives: The purpose of this study was to examine the temporal trends in demographics, clinical characteristics, management strategies, and in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (CS-AMI) who underwent percutaneous coronary intervention (PCI) from the Cath-PCI Registry (2005 to 2013).

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Left Main Stenting in Comparison With Surgical Revascularization. 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial

Pawel E. Buszman, MD, PhDa,b; Piotr P. Buszman, MD, PhDa,c; Iwona Banasiewicz-Szkróbka, MD, PhDa; Krzysztof P. Milewski, MD, PhDa; Aleksander Żurakowski, MD, PhDa; Bartłomiej Orlik, MD, PhDa; Magda Konkolewska, MDa; Błażej Trela, MDa; Adam Janas, MDa; Jack L. Martin, MDd; R. Stefan Kiesz, MDe; Andrzej Bochenek, MD, PhDa,b

Objectives: This study has reported 10-year clinical follow-up of patients enrolled in the prospective, randomized LE MANS (Left Main Stenting) trial.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes? A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials

Jeffrey D. Wessler, MD, MPhila; Philippe Généreux, MDa,b,c; Roxana Mehran, MDb,d; Girma Minalu Ayele, PhDb; Sorin J. Brener, MDb,e; Margaret McEntegart, MD, PhDf; Ori Ben-Yehuda, MDa,b; Gregg W. Stone, MDa,b; Ajay J. Kirtane, MD, SMa,b

Objectives: This study sought to determine the extent to which individual components of intraprocedural thrombotic events (IPTEs) are associated with adverse events.